Return to Special Authority drug list
Generic name |
etanercept |
|
Brand name |
Strength & form |
|
Brenzys® |
50 mg solution for injection in a pre-filled syringe or pre-filled auto-injector |
|
Erelzi® |
25 mg and 50 mg solution for injection in a pre-filled syringe, 50 mg pre-filled auto-injector |
|
Rymti® |
25 mg and 50 mg solution for injection in a pre-filled syringe, 50 mg pre-filled auto-injector |
Special Authority criteria |
Approval period |
Treatment of rheumatoid arthritis according to established criteria1 when prescribed by a rheumatologist |
First approval: 1 year Renewal: 1 year to indefinite |
Treatment of ankylosing spondylitis according to established criteria1 when prescribed by a rheumatologist |
First approval: 1 year Renewal: 1 year to indefinite |
Treatment of psoriatic arthritis according to established criteria1 when prescribed by a rheumatologist |
First approval: 1 year Renewal: 1 year to indefinite |
Treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (pJIA) for patients 4 years and older, who, due to intolerance or lack of efficacy, have not adequately responded to methotrexate |
First approval: 1 year Renewal: 1 year to indefinite |
Treatment of moderate to severe plaque psoriasis according to established criteria1 when prescribed by a dermatologist |
First approval: 12 weeks Renewal: 1 year |
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
Plaque psoriasis